Latest News

  • Era of Personalized Medicine & Therapeutic Drug Monitoring in Autoimmune Diseases

    Diagnostics World News | TNF-α inhibitors have been crucial in many diseases including IBD, psoriasis, cancer, and Alzheimer’s disease, among others. What exactly are we measuring to determine drug effectiveness and how can we, as clinicians, determine if these drugs are improving patient’s symptoms?

    May 13, 2021
  • St Jude Releases Early Data on Asymptomatic Cases Among Vaccinated Healthcare Workers

    Diagnostics World News | In a research letter published last week in JAMA, St Jude Children’s Research Hospital researchers reported early findings tracking asymptomatic COVID-19 among vaccinated healthcare workers. The findings will inform both individual vaccination plans as well as institutional screening and testing programs.

    May 12, 2021
  • Ginkgo, Quest Collaborate To Expand In-School COVID-19 Pooled Testing

    Diagnostics World News | Ginkgo Bioworks has added a collaboration with Quest Diagnostics to its existing network of COVID-19 testing labs. Quest Diagnostics has capacity to perform 300,000 COVID-19 PCR tests a day; the added capacity will give Ginkgo the capacity to test all 60 million US students, teachers and staff, every week.

    May 7, 2021
  • Quidel, Abbott Begin Rollout of At-Home COVID-19 Antigen Tests

    Diagnostics World News | Quidel and Abbott have introduced at-home COVID-19 antigen tests that do not require a prescription and deliver results in just minutes. They are also completely independent of doctor oversight or reporting of results.

    May 6, 2021
  • New COVID-19 Diagnostics, Myriad Sells myPath, Nanoscale Diagnostic Sensors

    Diagnostics World News | New sequencing project looks at developmental differences, Castle Biosciences to acquire Myriad’s myPath, AI tools for cystic fibrosis detection, updates in COVID-19 diagnostics, and more new products and updates from around the industry.

    May 3, 2021
  • New Business Direction for Qlucore, Preconception Genetics, and Genome Engineering

    Diagnostics World News | New funding for rapid, easy-to-use PCR and near-patient sepsis diagnostics; a seed round for preconception genetic risk modeling; and a new business for Qlucore: cancer diagnostics.

    Apr 29, 2021
  • Could Activity Become A Vital Sign?

    Diagnostics World News | Passive activity tracking could one day be used as a primary vital sign along with measures of body temperature, pulse, respiratory rate, and blood pressure. The “activity index” (Ai) of patients could be valuable to physicians when evaluating patients in the emergency room with vague complaints and deciding on degree of diagnostic testing.

    Apr 26, 2021
  • Aegis Expanded to COVID-19 Testing Supported By Expandable Infrastructure

    Diagnostics World News | At the beginning of 2020, Aegis Sciences was a Nashville-based national toxicology lab, with a small biopharma lab. Today, they can do more than 110,000 COVID-19 tests per day. It’s been a busy year.

    Apr 21, 2021
  • Sema4, NorthShore Announce System-Wide Genomics, Research Partnership

    Diagnostics World News | Sema4 has launched a strategic partnership with NorthShore University HealthSystem announcing the availability of a system-wide data-driven genomics program that uses predictive analytics to help clinicians and patients prevent, detect, and treat diseases at an early stage.

    Apr 19, 2021
  • Machine Learning Ranks Cancer Drugs Based On Proteome Of Tumors

    Diagnostics World News | A UK company has released Drug Ranking Using Machine Learning (DRUML), an open-source ensemble of predictive models trained for drugs with different modes of action that can help clinicians pick the most appropriate cancer drugs for individual patients from among most (412 of 659) of the options now available.

    Apr 14, 2021
  • Researchers Pursue Early Detection of Ovarian Cancer, Foresee Possibility of At-Home Test

    Diagnostics World News | A new study led by University of Minnesota Medical School researchers suggests that Pap test samples and cervical swabs may be a useful source of tumor-specific biomarkers for ovarian cancer, and the group sees potential for the development of an early detection test.

    Apr 13, 2021
  • Where We Stand in Realizing the Promise of Digital Pathology

    Diagnostics World News | A year into COVID-19, we see that it has cast an unexpected spotlight on digital pathology. It has accelerated adoption as laboratories’ ability to operate has increasingly become tied to their digital footprint. In doing so, it has also laid the foundation for laboratories to realize the benefits of the digital transformation beyond remote work, positioning them to meet future challenges and capitalize on the opportunity ahead.

    Apr 9, 2021
  • Disease Trajectories Aim To Reduce Medical Misdiagnoses

    Diagnostic World News | Getting a diagnosis right when diseases share symptoms or co-occur due to advanced age or unhealthy habits may require a more holistic view of the situation than can be gleaned from the typical physician-patient encounter.

    Apr 6, 2021
  • Follow the Money: Point-of-Care Dx, AI in Diagnostics, Data Management

    Diagnostics World News | Paige nets another influx of cash for AI-based pathology, and Inflammatix closes a round for its novel immune-response diagnostics portfolio. Investments in point-of-care diagnostics and liquid biopsies. And new investment funds for late-stage companies and public health.

    Apr 1, 2021
  • Variants Vs. Lineages: How We Track SARS-CoV-2 Changes

    Diagnostics World News | Color Health is adding its voice to calling for more granularity in how we name and track SARS-CoV-2 variants says Alicia Zhou, Chief Scientific Officer at Color. “There really is a difference between tracking variants versus tracking lineages,” Zhou told Diagnostics World.

    Mar 30, 2021
  • AMP Survey Shows Reimbursement Not Aligned With Molecular Test Costs

    Diagnostics World News | The Association for Molecular Pathology released survey results outlining the effort required to interpret molecular tests. As the menu of—and demand for—molecular tests grow, so does the burden of effort and cost associated with interpretation and results reporting. Reimbursement isn’t keeping up, AMP claims.

    Mar 29, 2021
  • New Framework For Developing Polygenic Risk Scores

    Diagnostics World News | Last week a research team published a 22-item framework in Nature that identifies the minimal polygenic risk score-related information that scientists should include in their studies.

    Mar 25, 2021
  • Screening Algorithm Flags Patients At Risk Of Suicide

    Diagnostics World News | The suicide rate in the United States is increasing. Suicide prevention begins with risk identification, but it is impossible to screen all of the individuals within a healthcare system. Vanderbilt University Medical Center researchers develop an AI tool that can screen EHRs and flag at-risk patients.

    Mar 22, 2021
  • XPRIZE Names Winners In Rapid COVID Testing Competition

    Diagnostics World News | XPRIZE has announced five winning teams in the $6M XPRIZE Rapid Covid Testing competition. Chosen by an independent panel of judges, the winning solutions are radically affordable compared to what is currently available on the market, and are comparable to commercial offerings at measuring sensitivity, specificity, and limit of detection—with a maximum turnaround time of 12 hours from sample to result.

    Mar 17, 2021
  • Promising Forecast For Doppler Radar-Based Diagnostics

    Diagnostics World News | Experts in basic medical sciences, biomedical engineering, and physics at Purdue University have collaborated to develop Doppler spectroscopy—the technique used to reveal the existence of extrasolar planetary systems—to study bacterial invasions of healthy tissue.

    Mar 16, 2021